491 related articles for article (PubMed ID: 33078282)
1. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
2. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
6. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
8. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
12. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
13. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
15. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
17. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
[TBL] [Abstract][Full Text] [Related]
18. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
19. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
20. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
